Generative AI and Automation for Longevity and Sustainability
Insilico Medicine develops breakthrough solutions using generative artificial intelligence to accelerate drug discovery and development for diseases like cancer, fibrosis, immunity, and CNS disorders. The company aims to extend healthy productive longevity by reducing time and cost in bringing life-saving medications to patients. Platforms include Chemistry42, Biology42, and Pharma.ai.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
